Multicenter evaluation of rectal cancer reimaging post neoadjuvant (MERRION) therapy.
Authors
Hanly, Ann MRyan, Elizabeth M
Rogers, Ailín C
McNamara, Deborah A
Madoff, Robert D
Winter, Desmond C
Affiliation
*Centre for Colorectal Disease, St Vincent's University Hospital, Elm Park, Dublin, Ireland †Beaumont Hospital, Dublin, Ireland ‡University of Minnesota Medical Center, Minnesota, Minneapolis, MN.Issue Date
2014-04Keywords
CANCERLocal subject classification
CANCER, RECTALMAGNETIC RESONANCE IMAGING
MeSH
AdultAged
Aged, 80 and over
Chemoradiotherapy, Adjuvant
Cohort Studies
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Preoperative Care
Rectal Neoplasms
Rectum
Retrospective Studies
Treatment Outcome
Metadata
Show full item recordCitation
Hanly AM et al. Multicenter evaluation of rectal cancer reimaging post neoadjuvant (MERRION) therapy. Ann. Surg. 2014, 259 (4):723-7Journal
Annals of surgeryDOI
10.1097/SLA.0b013e31828f6c91PubMed ID
23744576Abstract
The aim of this study was to evaluate the utility of reimaging rectal cancer post-CRT (chemoradiotherapy) with magnetic resonance (MR) imaging of the pelvis for local staging and computed tomography of thorax, abdomen, and pelvis (CT TAP) to identify distant metastases.Item Type
ArticleLanguage
enISSN
1528-1140ae974a485f413a2113503eed53cd6c53
10.1097/SLA.0b013e31828f6c91